Sucampo Pharmaceuticals Inc. (SCMP) Broke Out On Better Than Expected Q4 Results

Sucampo Pharmaceuticals Inc. (SCMP) reported fourth quarter adjusted EPS of $0.43 Tuesday morning, up from $0.21 in the prior year period. Analysts expected EPS of $0.19. Full year 2016 adjusted EPS is expected to be between $0.97 and $1.07. The consensus estimate is for EPS of $1.09.

from RTT - Before the Bell http://ift.tt/1QDdZ8N
via IFTTT